ES2130136T3 - Dispositivo dispensador. - Google Patents

Dispositivo dispensador.

Info

Publication number
ES2130136T3
ES2130136T3 ES91905164T ES91905164T ES2130136T3 ES 2130136 T3 ES2130136 T3 ES 2130136T3 ES 91905164 T ES91905164 T ES 91905164T ES 91905164 T ES91905164 T ES 91905164T ES 2130136 T3 ES2130136 T3 ES 2130136T3
Authority
ES
Spain
Prior art keywords
closed
capsule
dispenser device
lactose
man
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905164T
Other languages
English (en)
Inventor
Howard Norman Ernest Stevens
Abdul Rashid
Massoud Bakhshaee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Application granted granted Critical
Publication of ES2130136T3 publication Critical patent/ES2130136T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Seal Device For Vehicle (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Refuse Collection And Transfer (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Massaging Devices (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UN DISPOSITIVO DE LIBERACION CONTROLADA ESPECIALMENTE UNA FORMA DE DOSIFICACION ORAL PARA EL HOMBRE QUE COMPRENDE UNA CAPSULA IMPERMEABLE AL AGUA QUE TIENE AL MENOS UN ORIFICIO QUE SE ENCUENTRA CERRADO POR UN TAPON DISPERSIBLE EN EL AGUA. PREFERIBLEMENTE LA CAPSULA ES UN CILINDRO FORMADO POR EJEMPLO DE POLIETILENO CERRADO EN UN EXTREMO. EL EXTREMO ABIERTO SE CIERRA POR UNA TABLETA FORMADA POR EJEMPLO POR COMPRESION DIRECTA DE UN EXCIPIENTE FARMACEUTICO TAL COMO LA LACTOSA.
ES91905164T 1990-03-02 1991-03-01 Dispositivo dispensador. Expired - Lifetime ES2130136T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909004702A GB9004702D0 (en) 1990-03-02 1990-03-02 Dispensing device

Publications (1)

Publication Number Publication Date
ES2130136T3 true ES2130136T3 (es) 1999-07-01

Family

ID=10671894

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905164T Expired - Lifetime ES2130136T3 (es) 1990-03-02 1991-03-01 Dispositivo dispensador.

Country Status (20)

Country Link
EP (2) EP0517771B1 (es)
JP (1) JP3247693B2 (es)
KR (1) KR0177178B1 (es)
AT (1) ATE178790T1 (es)
AU (1) AU646244B2 (es)
CA (1) CA2077342C (es)
DE (1) DE69131129T2 (es)
DK (1) DK0517771T3 (es)
ES (1) ES2130136T3 (es)
FI (1) FI108400B (es)
GB (2) GB9004702D0 (es)
GR (1) GR3030007T3 (es)
HU (1) HU218675B (es)
IE (1) IE65251B1 (es)
NO (1) NO923397D0 (es)
NZ (1) NZ237290A (es)
PT (1) PT96921B (es)
RU (1) RU2094044C1 (es)
WO (1) WO1991012795A1 (es)
ZA (1) ZA911526B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
CA2193806A1 (en) * 1994-06-22 1995-12-28 Michael Cardamone Controlled release device and method
EP0940084A1 (en) * 1998-03-06 1999-09-08 Soremartec S.A. A composite food product and process for manufacturing same
GB2374582A (en) 2001-04-20 2002-10-23 Reckitt Benckiser Water soluble container containing a composition
GB2375516A (en) * 2001-05-17 2002-11-20 Reckitt Benckiser Water soluble injection moulded container
GB2375517A (en) * 2001-05-17 2002-11-20 Reckitt Benckiser A water-soluble injection moulded container
WO2010103367A1 (en) 2009-03-09 2010-09-16 Council Of Scientific & Industrial Research Pulsatile release composition of therapeutic agent
US8251837B2 (en) * 2010-08-11 2012-08-28 Nike, Inc. Floating golf ball
RU2553310C2 (ru) * 2013-05-07 2015-06-10 Общество с ограниченной ответственностью "ЭДВАНСД ТРЕЙДИНГ" Капсульная форма клофазимина
TW201613565A (en) * 2014-10-15 2016-04-16 Bio Peptide Enhancer Tech Co Ltd Controlled release sealing capsule in stomach, duodenum, jejunum, ileum and colon
UY38610A (es) 2019-03-14 2020-08-31 Univ Greifswald Forma de dosificación farmacéutica para aplicación a membranas mucosas y métodos para producir la misma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
FR2100858B1 (es) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
BE794951A (fr) * 1972-02-03 1973-05-29 Parke Davis & Co Conditionnement soluble dans l'eau
GB2094256B (en) * 1981-03-05 1984-08-22 Standard Telephones Cables Ltd Controlled delivery capsule
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4898733A (en) 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
GB2189390B (en) * 1986-04-16 1989-12-28 Stc Plc Material dispenser, e.g. for use as rumen boluses
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
DE69001831T2 (de) * 1989-02-16 1993-09-16 British Tech Group Wirkstoffabgabevorrichtung.

Also Published As

Publication number Publication date
WO1991012795A1 (en) 1991-09-05
NO923397L (no) 1992-08-31
EP0878190A1 (en) 1998-11-18
DE69131129D1 (de) 1999-05-20
HUT62464A (en) 1993-05-28
EP0517771B1 (en) 1999-04-14
ZA911526B (en) 1992-11-25
AU646244B2 (en) 1994-02-17
IE910693A1 (en) 1991-09-11
CA2077342C (en) 2001-04-24
GR3030007T3 (en) 1999-07-30
GB2241485A (en) 1991-09-04
FI923924A0 (fi) 1992-09-01
FI108400B (fi) 2002-01-31
ATE178790T1 (de) 1999-04-15
AU7443891A (en) 1991-09-18
CA2077342A1 (en) 1991-09-03
PT96921A (pt) 1993-03-31
NZ237290A (en) 1994-11-25
GB2241485B (en) 1994-01-12
NO923397D0 (no) 1992-08-31
HU218675B (hu) 2000-10-28
IE65251B1 (en) 1995-10-18
HU9202810D0 (en) 1993-04-28
DE69131129T2 (de) 1999-10-14
JP3247693B2 (ja) 2002-01-21
DK0517771T3 (da) 1999-10-25
JPH05506845A (ja) 1993-10-07
KR0177178B1 (en) 1999-03-20
RU2094044C1 (ru) 1997-10-27
PT96921B (pt) 1999-07-30
FI923924L (fi) 1992-09-01
GB9104321D0 (en) 1991-04-17
GB9004702D0 (en) 1990-04-25
EP0517771A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
ES491621A0 (es) Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
BG104476A (en) Therapeutical form for tolterodin with controlled release
ES2161690T3 (es) Formulaciones farmaceuticas.
LU91555I2 (fr) "Brinzolamide et timolol optionnellement sous de sels pharmaceutiquement acceptables te que la combination du produit brinzolamide/timolol maléate (AZARGA)"
EP0355470A3 (en) Pharmaceutical form with sustained release, and process for its preparation
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
MX9204776A (es) Forma de dosis para surtir farmaco en un periodo corto
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
BR0115382A (pt) Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica
PE8298A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol para administracion oral
ATE295160T1 (de) Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen
CA2077342A1 (en) Dispensing device
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2149341T3 (es) Expulsion de un material a partir de un dispositivo de liberacion.
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
PA8523101A1 (es) Composicion de eletriptan en forma de particulas
ES2097952T3 (es) Comprimidos de liberacion programada que contienen naproxeno.
GR1000989B (el) Μεθοδος παρασκευης συνθεσεως για θεραπεια οστεοπορωσης και ορμονικης ανισορροπιας.
ES2129563T3 (es) Empleo de una combinacion de un inhibidor de la enzima convertidora de angiotensina y un antagonista del calcio para el tratamiento de una proteinuria.
NO304011B1 (no) Anvendelse av atipamezol til fremstilling av et medisinsk preparat for behandling av menns impotens
IT1269412B (it) Apparecchio distributore di farmaci

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517771

Country of ref document: ES